C. Shaw, R. Andersen, . Sterol-glucoside, and . Toxins, Google Patents, 2002.

E. Tissandié, Vitamine D : M??tabolisme, r??gulation et maladies associ??es, m??decine/sciences, vol.22, issue.12, pp.1095-1100, 2006.
DOI : 10.1051/medsci/200622121095

A. Martin, Apports Nutritionnels Conseillés Pour La Population Française, Tec & Doc, vol.3, pp.77-80, 2001.

C. Benhamou and J. Souberbielle, La Vitamine D Chez L'adulte. Sauramps medical, pp.12-13, 2015.

D. Vitamine, Sources Alimentaires et Besoins Nutritionnels, ANSES

H. Bischoff-ferrari and U. Keller, Recommandations de La Commission Fédérale de L'alimentation Concernant L'apport de Vitamine D, Forum Med Suisse, pp.775-778, 2012.

D. Vital, D. Le-jeune, and C. , Guide Pratique Des Médicaments. 33e Édition, Maloine, vol.24, p.1657, 2014.

D. Vital, D. Le-jeune, and C. , Guide Pratique Des Médicaments. 33e Édition, Maloine, vol.24, pp.1656-1659, 2015.

R. Vieth, Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety

A. Brickman and J. Coburn, Vitamin D and Your Health: Breaking Old Rules, Raising New Hopes, Harvard Mens Health Watch, vol.11, issue.7, pp.1-5, 2007.

J. Schlienger, Métabolisme Phosphocalcique Aspects Pratiques Chez L'adulte, Hopital de Hautepierre, pp.2-3, 2012.

. Accessed, www.pole-sante-desallymes .fr/cms, p.22, 2015.

C. Cormier and E. Maury, Effect of Vitamin D deficiency on cardiovascular risk, Journal des Maladies Vasculaires, p.35237, 2010.

T. Thomas, Comment Prévenir Les Fractures Dues À L'ostéoporose, HAS FMOSTEO, pp.3-4, 2007.

F. Rang, Pharmacology 5e, 2006.

A. Cruz-jentoft and J. Baeyens, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age and Ageing, vol.39, issue.4, pp.412-435, 2010.
DOI : 10.1093/ageing/afq034

A. Vandervoort, Aging of the human neuromuscular system, Muscle & Nerve, vol.268, issue.1, pp.17-25, 2002.
DOI : 10.1002/mus.1215

E. Alix and B. Vellas, Traité de La Nutrition de La Personne Agée, p.175, 2009.

Y. Boirie, Physiopathological mechanism of sarcopenia, The Journal of Nutrition, Health and Aging, vol.359, issue.Suppl, pp.717-723, 2009.
DOI : 10.1007/s12603-009-0203-x

H. Bischoff-ferrari and B. Dawson-hughes, Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials, BMJ, vol.339, issue.oct01 1, pp.3692-3730, 2009.
DOI : 10.1136/bmj.b3692

P. Engel and G. Fagherazzi, Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort, Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.1, pp.187-198, 2011.
DOI : 10.1158/1055-9965.EPI-10-1039

C. Cormier and E. Maury, Effect of Vitamin D deficiency on cardiovascular risk, Journal des Maladies Vasculaires, p.35237, 2010.

M. Hewison, Antibacterial effects of vitamin D, Nature Reviews Endocrinology, vol.9, issue.6, pp.337-345, 2011.
DOI : 10.1038/nrendo.2010.226

K. Yin and D. Agrawal, Vitamin D and inflammatory diseases Center for Clinical and Translational Science, J Inflamm Res, vol.7, pp.69-87, 2014.

J. Viard and J. Souberbielle, Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study, AIDS, vol.25, issue.10, pp.1305-1315, 2011.
DOI : 10.1097/QAD.0b013e328347f6f7

K. Gibney and L. Macgregor, Vitamin D Deficiency Is Associated with Tuberculosis and Latent Tuberculosis Infection in Immigrants from Sub-Saharan Africa, Clinical Infectious Diseases, vol.46, issue.3, pp.443-449, 2008.
DOI : 10.1086/525268

P. Selvaraj, Vitamin D, Vitamin D Receptor, and Cathelicidin in the Treatment of Tuberculosis
DOI : 10.1016/B978-0-12-386960-9.00013-7

C. Pierrot-desseilly and J. Souberbielle, Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?, Brain, vol.133, issue.7, pp.1869-88, 2010.
DOI : 10.1093/brain/awq147

E. Delvin and B. Salle, Vitamine D et sclérose en plaque. Sauramps Medical, pp.93-102, 2014.

M. Cantorna and C. Hayes, 25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis, Proc Natl Acad SCI, vol.193, pp.7861-7865, 1996.

J. Richards and G. Thanassoulis, PLOS Medicine: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study, PLoS Med, vol.12, issue.8, p.1001866, 2015.

L. Jeffery and F. Burke, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production in of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 ans FoxP3, J Immunol, vol.1183, issue.9, pp.5458-67, 2009.

S. Patel and T. Farragher, Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis, Arthritis & Rheumatism, vol.16, issue.7, pp.2143-2152, 2007.
DOI : 10.1002/art.22722

H. Deluca and M. Cantorna, Vitamin D: its role and uses in immunology, The FASEB Journal, vol.15, issue.14, pp.2579-85, 2001.
DOI : 10.1096/fj.01-0433rev

B. Terrier and N. Derian, Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation, Arthritis Research & Therapy, vol.14, issue.5, pp.221-58, 2012.
DOI : 10.1038/ng1180

URL : https://hal.archives-ouvertes.fr/inserm-00768700

A. Abou-raya and S. Abou-raya, The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial, The Journal of Rheumatology, vol.40, issue.3, pp.265-72, 2013.
DOI : 10.3899/jrheum.111594

D. Martins and D. Pan, Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States, Archives of Internal Medicine, vol.167, issue.11, pp.1159-65, 2007.
DOI : 10.1001/archinte.167.11.1159

S. Pilz and A. Tomaschitz, Vitamin D deficiency and myocardial diseases, Molecular Nutrition & Food Research, vol.93, pp.1103-1116, 2010.
DOI : 10.1002/mnfr.200900474

C. Cormier and M. Courdebaisse, Effect of vitamin D deficiency on cardiovascular risk, J

S. Chen and D. Glenn, Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart, Hypertension, vol.52, issue.6, pp.1106-1118, 2008.
DOI : 10.1161/HYPERTENSIONAHA.108.119602

M. Courdebaisse and C. Cormier, Vitamine D et système cardiovasculaire La vitamine D chez l'adulte, Sauramps médical, vol.12, p.141, 2014.

S. Rostand, Ultraviolet Light May Contribute to Geographic and Racial Blood Pressure Differences, Hypertension, vol.30, issue.2, pp.150-156, 1997.
DOI : 10.1161/01.HYP.30.2.150

S. Kunutsor and T. Apekey, Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants, European Journal of Epidemiology, vol.307, issue.7, pp.205-226, 2013.
DOI : 10.1007/s10654-013-9790-2

M. Pfeifer and B. Begerow, Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.4, pp.1633-1670, 2001.
DOI : 10.1210/jc.86.4.1633

. Qu-'est-ce-que-le-diabète, Type 1, Définition, Symptômes, Causes, Traitements, Complications... | Diabète-AFD. Fédération Française Des Diabétiques, 2016.

J. Nagpal and J. Pande, supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men, Diabetic Medicine, vol.95, issue.1, pp.19-27, 2009.
DOI : 10.1111/j.1464-5491.2008.02636.x

R. Milner and C. Hales, Der Einflu??? von Calcium und Magnesium auf die Freisetzung von Insulin aus Kaninchen-Pankreas, in virto, Diabetologia, vol.129, issue.1, pp.47-56, 1967.
DOI : 10.1007/BF01269910

L. De-las-fuentes and L. Bernal-mizrachi, Vitamin d suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte

E. Läärä and A. Reunanen, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study, Lancet, vol.358, issue.9292, pp.1500-1503, 2001.

S. Peller, SKIN IRRITATION AND CANCER IN THE U. S. NAVY, The American Journal of the Medical Sciences, vol.194, issue.3, pp.326-333, 1937.
DOI : 10.1097/00000441-193709000-00004

W. Grant, An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation, Cancer, vol.91, issue.6, pp.1867-75, 2002.
DOI : 10.1002/cncr.10427

E. Elstner and I. Grillier, Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells, Cancer Res, vol.56, issue.15, pp.3570-76, 1996.

D. Freedman and A. Looker, Prospective Study of Serum Vitamin D and Cancer Mortality in the United States, JNCI Journal of the National Cancer Institute, vol.99, issue.21, pp.1594-1602, 2007.
DOI : 10.1093/jnci/djm204

C. Garland and E. Gorham, Vitamin D and prevention of breast cancer: Pooled analysis, The Journal of Steroid Biochemistry and Molecular Biology, vol.103, issue.3-5, pp.2705-2714, 2007.
DOI : 10.1016/j.jsbmb.2006.12.007

P. Goodwin and D. Cescon, Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer, Breast Cancer Res Treat, vol.134, issue.2, pp.759-67, 2012.

P. Engel and G. Fagherazzi, Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested

M. Manson and S. Bassuk, The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease, Contemporary Clinical Trials, vol.33, issue.1
DOI : 10.1016/j.cct.2011.09.009

M. Yanlei and Z. Peng, Association Between Vitamin D and Risk of Colorectal Cancer

E. Gorham and C. Garland, Optimal Vitamin D Status for Colorectal Cancer Prevention, American Journal of Preventive Medicine, vol.32, issue.3, pp.210-216, 2007.
DOI : 10.1016/j.amepre.2006.11.004

D. Vitamine and . Cancer-de-la-prostate, Forum sur la prostate-Association Nationale des Malades du Cancer de la, Prostate, issue.2, 2012.

E. Giovannucci, Vitamin D and Cancer Incidence in the Harvard Cohorts, Annals of Epidemiology, vol.19, issue.2, pp.84-88, 2009.
DOI : 10.1016/j.annepidem.2007.12.002

T. Beer and C. Ryan, Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators, Journal of Clinical Oncology, vol.25, issue.6, pp.1900-1901, 2008.
DOI : 10.1200/JCO.2006.06.8197

J. Manus, Inecalcitol, analogue de la vitamine D et cancer de la prostate Revue francophone des laboratoires, p.16, 2010.